NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Household & Personal Products · USD

Kenvue Inc. (KVUE) Stock Analysis

Kenvue Inc. (KVUE) is a Household & Personal Products stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

KVUE

$19.04

−$0.24 (−1.24%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare KVUE with… →

KVUE Key Statistics

As of Oct 21, 2026
Trading
Open
$19.23
Previous Close
$19.28
Day's Range
19.02–19.27
52-Week Range
14.02–20.13
Volume
23.71M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.45
Valuation
Market Cap
$36.57B
P/E Ratio
22.14
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
15.36
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.53
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.37
EPS (ttm)Profit attributable to each share over the last twelve months.
0.86
Financials (FY)
Revenue (FY)
$15.12B−2.14%
Net Income (FY)
$1.47B+42.72%
Profit marginThe share of revenue left as profit after all costs and taxes.
10.76%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.92B
1-Year Return
+35.26%
Dividend and dates
Dividend
$0.84+4.36%
Ex-Dividend Date
September 21, 2026
Earnings Date
November 5, 2026estimated
Avg Volume
22.51M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, KVUE closed at $19.04, +35.26% over 1 year.

Kenvue Inc. (KVUE) has a market capitalization of $36.57B.

In fiscal 2025, KVUE reported revenue of $15.12B.

KVUE Stock Return by Calendar Year

Kenvue Inc. (KVUE) return since May 2023: what $10,000 became

1 year
$10,000 $13,526
+35.26%
3 years
$10,000 $11,056
+10.56%
Since May 2023
$10,000 $8,182
−18.18%

If you had invested $10,000 in Kenvue Inc. (KVUE) at the close on May 4, 2023, the earliest close on record here, it would have been worth $8,182 at the close on October 21, 2026: −18.18% in total, −5.62% a year, with dividends reinvested, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+15.61%
2025−15.85%
2024+3.12%
2023 (partial year)−18.44%

As of October 21, 2026.

KVUE Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$15.12B$1.47B9.7%
2024$15.46B$1.03B6.7%
2023$15.44B$1.66B10.8%
2022$14.95B$2.06B13.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$15.12B$8.79B$2.72B$1.47B9.7%
2024$15.46B$8.96B$2.63B$1.03B6.7%
2023$15.44B$8.64B$2.49B$1.66B10.8%
2022$14.95B$8.29B$2.69B$2.06B13.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

KVUE Dividend History

$0.83+2.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.844—
2025$0.834+2.0%
2024$0.814+102.5%
2023$0.402—

Most recent payment: $0.21 per share, ex-dividend September 21, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

KVUE Valuation vs Household & Personal Products Median

Median of 32 stocks
MetricKVUEHousehold & Personal Products medianvs median
P/E22.1422.923% below
P/S ratio2.371.3378% above
Profit margin10.76%1.72%9.0 pts above

Medians across 32 Household & Personal Products stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Kenvue Inc. (KVUE) is capitalised at $36.57B on the latest close. The company sits in the Consumer Defensive sector, in the Household & Personal Products industry. The company reports 21,780 employees.

KVUE last closed at $19.04 on October 21, 2026. That is −$0.24 (−1.24%) against the previous close. Over the past 52 weeks the price has ranged from $14.02 to $20.13. The latest close sits 35.81% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $15.12B. Against the prior fiscal year total of $15.46B, that is a change of −2.14%. Net income for the same year was $1.47B. That is +42.72% against the prior fiscal year. Profit margin runs at 10.76%. That is 9 percentage points above the Household & Personal Products median of 1.72%. Trailing earnings per share are 0.86.

Across the 4 fiscal years on file, revenue moves from $14.95B in 2022 to $15.12B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

KVUE trades at a trailing price-to-earnings ratio of 22.14. That is 3.38% below the Household & Personal Products median of 22.92. On forward earnings the ratio is 15.36. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.53. Measured against sales, the shares trade at 2.37 times revenue. On price-to-sales that is 78.12% above the Household & Personal Products median of 1.33. The medians here are taken across 32 Household & Personal Products companies that report the metric.

Over the trailing twelve months the total return is +35.26%. Across 3 years the annualized return works out at +3.40%. Beta against the wider market is reported at 0.45. Daily returns over the trailing 3 years annualize to a volatility of 28.47%.

Growth & Income

The trailing dividend yield is 4.36%. That is 1.4 percentage points above the Household & Personal Products median yield of 3.01%. The indicated annual rate is $0.84 a share. The ex-dividend date on file is September 21, 2026. Dividends are recorded for 4 calendar years; 2026 shows 4 payments totalling $0.84 a share. The year before, 2025, totalled $0.83 a share.

2026 is still running; the total return is +15.61% year to date. The strongest complete calendar year on file is 2024 at +3.12%; the weakest is 2025 at −15.85%.

Peer Comparison

Kenvue Inc. (KVUE) operates in the Household & Personal Products industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Kenvue Inc. KVUE $36.57B 22.1
The Procter & Gamble Company PG $364.29B 23.7
Unilever PLC UL $138.69B 13.0
Colgate-Palmolive Company CL $75.02B 37.1

The Household & Personal Products industry average P/E ratio is 22.9x. Kenvue Inc. trades at a P/E of 22.1.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Household & Personal Products Stocks

PG

The Procter & Gamble Company

$364.29B

 UL

Unilever PLC

$138.69B

 CL

Colgate-Palmolive Company

$75.02B

 EL

The Estée Lauder Companies Inc.

$37.56B

 KMB

Kimberly-Clark Corporation

$35.47B

 CHD

Church & Dwight Co., Inc.

$24.79B
View all Household & Personal Products stocks →

Popular Consumer Defensive Stocks

WMT

Walmart Inc.

$937.46B

 COST

Costco Wholesale Corporation

$442.38B

 KO

The Coca-Cola Company

$398.76B

 PM

Philip Morris International Inc.

$307.76B

 PEP

PepsiCo, Inc. Common Stock

$183.56B
View all Consumer Defensive stocks →

About Kenvue Inc.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Visit website →